A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation

Cancer Immunology, Immunotherapy

Volumn 51, Issue 4, 2002, Pages 219-228

  Hida, Naoya ^a   Maeda, Yoshiaki ^b   Katagiri, Kazuko ^a   Takasu, Hideo ^c   Harada, Mamoru ^a   Itoh, Kyogo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

CTL; Immunotherapy; Peptide; Vaccine

Indexed keywords

PEPTIDE; TUMOR ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CELL SPECIFICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; PRIORITY JOURNAL; PROLYMPHOCYTE; PROTEIN DETERMINATION;

ANTIGENS, NEOPLASM; CELL CULTURE TECHNIQUES; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HERPESVIRUS 4, HUMAN; HLA-A ANTIGENS; HLA-A2 ANTIGEN; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE II; NEOPLASMS; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036257189     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-002-0273-7     Document Type: Article

References (28)

1. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
2. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restrictedtumor infiltrating lymphocytes
3. Identification of an immunodominant peptide of HER2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines
4. The life span of major histocompatibility complex-peptide complexes influences the effeciency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4
5. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide
6. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes
7. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
8. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients
9. Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer
10. Immunologic and therapeutic evaluation of synthetic peptide vaccine for the treatment of patients with metastatic melanoma
11. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
12. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
13. Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma
14. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas
15. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
16. The altered peptide ligand in relapsing MS study group. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
17. Conserved CTL epitopes within EBV latent membrane protein 2: A potential target for CTL-based tumor therapy
18. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2
19. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: Strong epitopes are derived from V regions of HIV-1
20. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease
21. HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides
22. Phenotypic analysis of antigen-specific T lymphocytes
23. Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens
24. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs
25. Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases
26. CD28/B7 system of T cell costimulation
27. Human effector memory T cells express CD86: A functional role in naive T cell priming
28. Printing proteins as microarrays for high-throughput function determination